Ankündigung • Jun 30
Lier Chemical Co.,LTD. to Report First Half, 2026 Results on Aug 28, 2026 Lier Chemical Co.,LTD. announced that they will report first half, 2026 results on Aug 28, 2026 Ankündigung • Mar 31
Lier Chemical Co.,LTD. to Report Q1, 2026 Results on Apr 25, 2026 Lier Chemical Co.,LTD. announced that they will report Q1, 2026 results on Apr 25, 2026 Reported Earnings • Mar 29
Full year 2025 earnings: EPS and revenues exceed analyst expectations Full year 2025 results: EPS: CN¥0.60 (up from CN¥0.27 in FY 2024). Revenue: CN¥9.01b (up 23% from FY 2024). Net income: CN¥478.8m (up 122% from FY 2024). Profit margin: 5.3% (up from 2.9% in FY 2024). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 20%. Earnings per share (EPS) also surpassed analyst estimates by 2.2%. Revenue is forecast to grow 7.5% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance. Ankündigung • Mar 28
Lier Chemical Co.,LTD., Annual General Meeting, Apr 17, 2026 Lier Chemical Co.,LTD., Annual General Meeting, Apr 17, 2026, at 14:40 China Standard Time. Location: 7F, Building 1, No. 16, Yuanyi Street, Pucheng District, Mianyang, Sichuan China Reported Earnings • Jan 24
Full year 2025 earnings released: EPS: CN¥0.60 (vs CN¥0.27 in FY 2024) Full year 2025 results: EPS: CN¥0.60 (up from CN¥0.27 in FY 2024). Revenue: CN¥9.01b (up 23% from FY 2024). Net income: CN¥478.8m (up 122% from FY 2024). Profit margin: 5.3% (up from 2.9% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to stay flat during the next 2 years compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance. Valuation Update With 7 Day Price Move • Jan 20
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to CN¥16.96, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 28x in the Chemicals industry in China. Total loss to shareholders of 2.9% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥27.05 per share. Ankündigung • Dec 31
Lier Chemical Co.,LTD. to Report Fiscal Year 2025 Results on Mar 28, 2026 Lier Chemical Co.,LTD. announced that they will report fiscal year 2025 results on Mar 28, 2026 Reported Earnings • Oct 25
Third quarter 2025 earnings released: EPS: CN¥0.14 (vs CN¥0.049 in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.14 (up from CN¥0.049 in 3Q 2024). Revenue: CN¥2.20b (up 19% from 3Q 2024). Net income: CN¥110.7m (up 184% from 3Q 2024). Profit margin: 5.0% (up from 2.1% in 3Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 63 percentage points per year, which is a significant difference in performance. Ankündigung • Sep 30
Lier Chemical Co.,LTD. to Report Q3, 2025 Results on Oct 25, 2025 Lier Chemical Co.,LTD. announced that they will report Q3, 2025 results on Oct 25, 2025 Ankündigung • Sep 16
Lier Chemical Co.,Ltd. Approves Interim Profit Distribution Plan for 2025 Lier Chemical Co.,LTD. held its 2nd Extraordinary General Meeting of 2025 on 12 September 2025, approved cash interim dividend (tax included) of CNY 2.00000000 per 10 shares for the year 2025. Ankündigung • Aug 28
Lier Chemical Co.,LTD. Approves Board Appointments, Effective 26 August 2025 Lier Chemical Co.,LTD. at its Extraordinary General Meeting held on 26 August 2025, approved election of Wei Dejia and Meng Qin as independent directors. Ankündigung • Jul 02
Lier Chemical Co.,LTD. to Report First Half, 2025 Results on Aug 28, 2025 Lier Chemical Co.,LTD. announced that they will report first half, 2025 results on Aug 28, 2025 Major Estimate Revision • Jun 17
Consensus EPS estimates fall by 10%, revenue upgraded The consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast increased from CN¥7.38b to CN¥7.45b. EPS estimate fell from CN¥0.653 to CN¥0.585 per share. Net income forecast to grow 55% next year vs 43% growth forecast for Chemicals industry in China. Consensus price target up from CN¥10.50 to CN¥12.00. Share price fell 2.8% to CN¥11.33 over the past week. Valuation Update With 7 Day Price Move • May 29
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CN¥11.86, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 20x in the Chemicals industry in China. Total loss to shareholders of 45% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥23.41 per share. Ankündigung • Apr 23
Lier Chemical Co.,LTD. Approves Cash Dividend for the Year 2024 Lier Chemical Co.,LTD. approved cash dividend of CNY 2.00000000 per 10 shares (tax included) for the year 2024, at its AGM held on 18 April 2025. Valuation Update With 7 Day Price Move • Apr 08
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CN¥10.28, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 19x in the Chemicals industry in China. Total loss to shareholders of 51% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥6.43 per share. New Risk • Apr 04
New minor risk - Dividend sustainability The dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 2.2% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (2.9% net profit margin). Major Estimate Revision • Apr 03
Consensus revenue estimates fall by 12% The consensus outlook for revenues in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from CN¥8.12b to CN¥7.11b. EPS estimate fell from CN¥0.683 to CN¥0.635 per share. Net income forecast to grow 138% next year vs 48% growth forecast for Chemicals industry in China. Consensus price target of CN¥10.50 unchanged from last update. Share price fell 3.1% to CN¥8.92 over the past week. Ankündigung • Mar 31
Lier Chemical Co.,LTD. to Report Q1, 2025 Results on Apr 25, 2025 Lier Chemical Co.,LTD. announced that they will report Q1, 2025 results on Apr 25, 2025 Reported Earnings • Mar 28
Full year 2024 earnings: EPS in line with analyst expectations despite revenue beat Full year 2024 results: EPS: CN¥0.27 (down from CN¥0.75 in FY 2023). Revenue: CN¥7.31b (down 6.9% from FY 2023). Net income: CN¥215.3m (down 64% from FY 2023). Profit margin: 2.9% (down from 7.7% in FY 2023). The decrease in margin was driven by lower revenue. Revenue exceeded analyst estimates by 12%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 26% per year, which means it has not declined as severely as earnings. Ankündigung • Mar 28
Lier Chemical Co.,LTD., Annual General Meeting, Apr 18, 2025 Lier Chemical Co.,LTD., Annual General Meeting, Apr 18, 2025, at 14:40 China Standard Time. Location: The Company's Meeting Room, Mianyang, Sichuan China Reported Earnings • Jan 25
Full year 2024 earnings released: EPS: CN¥0.27 (vs CN¥0.75 in FY 2023) Full year 2024 results: EPS: CN¥0.27 (down from CN¥0.75 in FY 2023). Revenue: CN¥7.31b (down 6.9% from FY 2023). Net income: CN¥215.3m (down 64% from FY 2023). Profit margin: 2.9% (down from 7.7% in FY 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has only fallen by 26% per year, which means it has not declined as severely as earnings. Ankündigung • Dec 31
Lier Chemical Co.,LTD. to Report Fiscal Year 2024 Results on Mar 28, 2025 Lier Chemical Co.,LTD. announced that they will report fiscal year 2024 results on Mar 28, 2025 Major Estimate Revision • Nov 07
Consensus EPS estimates fall by 71% The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥6.66b to CN¥6.52b. EPS estimate also fell from CN¥0.92 per share to CN¥0.27 per share. Net income forecast to grow 164% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target of CN¥10.50 unchanged from last update. Share price rose 6.1% to CN¥8.75 over the past week. Reported Earnings • Oct 31
Third quarter 2024 earnings released: EPS: CN¥0.049 (vs CN¥0.10 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.049 (down from CN¥0.10 in 3Q 2023). Revenue: CN¥1.86b (up 21% from 3Q 2023). Net income: CN¥39.0m (down 51% from 3Q 2023). Profit margin: 2.1% (down from 5.2% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has only fallen by 22% per year, which means it has not declined as severely as earnings. Ankündigung • Sep 30
Lier Chemical Co.,LTD. to Report Q3, 2024 Results on Oct 31, 2024 Lier Chemical Co.,LTD. announced that they will report Q3, 2024 results on Oct 31, 2024 Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CN¥8.02, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 58% over the past three years. Major Estimate Revision • Sep 05
Consensus revenue estimates decrease by 17% The consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast fell from CN¥8.05b to CN¥6.66b. EPS estimate unchanged from CN¥0.92 per share at last update. Chemicals industry in China expected to see average net income growth of 46% next year. Consensus price target down from CN¥11.50 to CN¥10.00. Share price was steady at CN¥7.19 over the past week. Reported Earnings • Aug 30
Second quarter 2024 earnings released: EPS: CN¥0.056 (vs CN¥0.26 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.056 (down from CN¥0.26 in 2Q 2023). Revenue: CN¥1.94b (down 4.4% from 2Q 2023). Net income: CN¥45.1m (down 78% from 2Q 2023). Profit margin: 2.3% (down from 10% in 2Q 2023). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has fallen by 31% per year, which means it is performing significantly worse than earnings. Ankündigung • Jun 29
Lier Chemical Co.,LTD. to Report First Half, 2024 Results on Aug 30, 2024 Lier Chemical Co.,LTD. announced that they will report first half, 2024 results on Aug 30, 2024 Reported Earnings • Apr 29
First quarter 2024 earnings released: EPS: CN¥0.06 (vs CN¥0.34 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.06 (down from CN¥0.34 in 1Q 2023). Revenue: CN¥1.39b (down 43% from 1Q 2023). Net income: CN¥47.8m (down 83% from 1Q 2023). Profit margin: 3.4% (down from 11% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has fallen by 18% per year, which means it is performing significantly worse than earnings. Ankündigung • Mar 30
Lier Chemical Co.,LTD. to Report Q1, 2024 Results on Apr 29, 2024 Lier Chemical Co.,LTD. announced that they will report Q1, 2024 results on Apr 29, 2024 Reported Earnings • Mar 23
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: EPS: CN¥0.75 (down from CN¥2.43 in FY 2022). Revenue: CN¥7.85b (down 23% from FY 2022). Net income: CN¥603.9m (down 67% from FY 2022). Profit margin: 7.7% (down from 18% in FY 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.5%. Earnings per share (EPS) also missed analyst estimates by 20%. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings. Ankündigung • Mar 23
Lier Chemical Co.,LTD., Annual General Meeting, Apr 12, 2024 Lier Chemical Co.,LTD., Annual General Meeting, Apr 12, 2024, at 14:40 China Standard Time. Valuation Update With 7 Day Price Move • Feb 12
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CN¥10.13, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 47% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥5.11 per share. Reported Earnings • Feb 01
Full year 2023 earnings released: EPS: CN¥0.75 (vs CN¥2.43 in FY 2022) Full year 2023 results: EPS: CN¥0.75 (down from CN¥2.43 in FY 2022). Revenue: CN¥7.85b (down 23% from FY 2022). Net income: CN¥603.9m (down 67% from FY 2022). Profit margin: 7.7% (down from 18% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings. Ankündigung • Dec 30
Lier Chemical Co.,LTD. to Report Fiscal Year 2023 Results on Mar 23, 2024 Lier Chemical Co.,LTD. announced that they will report fiscal year 2023 results on Mar 23, 2024 Price Target Changed • Nov 02
Price target decreased by 18% to CN¥14.00 Down from CN¥17.00, the current price target is an average from 2 analysts. New target price is 17% above last closing price of CN¥11.98. Stock is down 37% over the past year. The company is forecast to post earnings per share of CN¥0.94 for next year compared to CN¥2.43 last year. Major Estimate Revision • Oct 31
Consensus EPS estimates fall by 20% The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥8.93b to CN¥8.26b. EPS estimate also fell from CN¥1.25 per share to CN¥1.01 per share. Net income forecast to grow 16% next year vs 60% growth forecast for Chemicals industry in China. Consensus price target down from CN¥17.00 to CN¥16.00. Share price was steady at CN¥12.06 over the past week. Reported Earnings • Oct 25
Third quarter 2023 earnings released: EPS: CN¥0.10 (vs CN¥0.60 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.10 (down from CN¥0.60 in 3Q 2022). Revenue: CN¥1.54b (down 42% from 3Q 2022). Net income: CN¥80.3m (down 82% from 3Q 2022). Profit margin: 5.2% (down from 17% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Price Target Changed • Sep 09
Price target decreased by 21% to CN¥21.37 Down from CN¥27.03, the current price target is an average from 3 analysts. New target price is 61% above last closing price of CN¥13.26. Stock is down 40% over the past year. The company is forecast to post earnings per share of CN¥1.54 for next year compared to CN¥2.43 last year. Reported Earnings • Aug 26
Second quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.69 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.26 (down from CN¥0.69 in 2Q 2022). Revenue: CN¥2.03b (down 18% from 2Q 2022). Net income: CN¥205.0m (down 60% from 2Q 2022). Profit margin: 10% (down from 21% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. Reported Earnings • Apr 25
First quarter 2023 earnings released: EPS: CN¥0.34 (vs CN¥0.72 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.34 (down from CN¥0.72 in 1Q 2022). Revenue: CN¥2.44b (down 6.5% from 1Q 2022). Net income: CN¥274.7m (down 49% from 1Q 2022). Profit margin: 11% (down from 20% in 1Q 2022). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Major Estimate Revision • Mar 08
Consensus EPS estimates fall by 10%, revenue upgraded The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast increased from CN¥9.76b to CN¥10.7b. EPS estimate fell from CN¥2.59 to CN¥2.32 per share. Net income forecast to grow 1.3% next year vs 41% growth forecast for Chemicals industry in China. Consensus price target down from CN¥28.60 to CN¥26.55. Share price fell 2.5% to CN¥18.25 over the past week. Price Target Changed • Mar 04
Price target decreased by 20% to CN¥23.00 Down from CN¥28.60, the current price target is provided by 1 analyst. New target price is 26% above last closing price of CN¥18.29. Stock is down 28% over the past year. The company is forecast to post earnings per share of CN¥2.41 for next year compared to CN¥2.43 last year. Reported Earnings • Mar 02
Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2022 results: EPS: CN¥2.43 (up from CN¥1.46 in FY 2021). Revenue: CN¥10.1b (up 56% from FY 2021). Net income: CN¥1.81b (up 69% from FY 2021). Profit margin: 18% (up from 17% in FY 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 35%. Earnings per share (EPS) missed analyst estimates by 13%. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth. Reported Earnings • Jan 14
Full year 2022 earnings released: EPS: CN¥2.43 (vs CN¥1.46 in FY 2021) Full year 2022 results: EPS: CN¥2.43 (up from CN¥1.46 in FY 2021). Revenue: CN¥10.1b (up 56% from FY 2021). Net income: CN¥1.81b (up 69% from FY 2021). Profit margin: 18% (up from 17% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 2 experienced directors. 3 highly experienced directors. Assistant to the General Manager and Member of Supervisory Board Fen Fang Tan is the most experienced director on the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Major Estimate Revision • Oct 17
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 revenue forecast fell from CN¥8.64b to CN¥7.49b. EPS estimate increased from CN¥2.57 to CN¥2.64 per share. Net income forecast to shrink 5.7% next year vs 39% growth forecast for Chemicals industry in China . Consensus price target of CN¥28.60 unchanged from last update. Share price rose 8.7% to CN¥19.84 over the past week. Reported Earnings • Oct 13
Third quarter 2022 earnings released: EPS: CN¥0.60 (vs CN¥0.14 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.60 (up from CN¥0.14 in 3Q 2021). Revenue: CN¥2.66b (up 138% from 3Q 2021). Net income: CN¥444.5m (up 317% from 3Q 2021). Profit margin: 17% (up from 9.5% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth. Major Estimate Revision • Aug 15
Consensus revenue estimates increase by 13% The consensus outlook for revenues in 2022 has improved. 2022 revenue forecast increased from CN¥7.15b to CN¥8.07b. EPS estimate increased from CN¥1.88 to CN¥2.23 per share. Net income forecast to shrink 0.9% next year vs 41% growth forecast for Chemicals industry in China . Consensus price target up from CN¥29.07 to CN¥29.90. Share price rose 4.0% to CN¥24.23 over the past week. Ankündigung • Aug 09
Lier Chemical Co.,Ltd. Announces Management Appointments Lier Chemical Co.,LTD. announced at the EGM held on August 5, 2022 that the company approved election of Li Shuxiang, Li Shuxiang, Song Xiaopei, Hao Minhong, Li Jian, Li Jiang as non-independent directors; Li Shuanghai as independent director and Xiao Yu as non-employee supervisor. Reported Earnings • Aug 09
Second quarter 2022 earnings released: EPS: CN¥0.69 (vs CN¥0.39 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.69 (up from CN¥0.39 in 2Q 2021). Revenue: CN¥2.47b (up 47% from 2Q 2021). Net income: CN¥513.3m (up 81% from 2Q 2021). Profit margin: 21% (up from 17% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 11% compared to a 41% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 41% per year, which means it is significantly lagging earnings growth. Reported Earnings • Jul 07
Second quarter 2022 earnings released: EPS: CN¥1.42 (vs CN¥0.39 in 2Q 2021) Second quarter 2022 results: EPS: CN¥1.42 (up from CN¥0.39 in 2Q 2021). Revenue: CN¥5.08b (up 203% from 2Q 2021). Net income: CN¥1.05b (up 269% from 2Q 2021). Profit margin: 21% (up from 17% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 32% compared to a 41% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 35% per year, which means it is significantly lagging earnings growth. Reported Earnings • Apr 27
First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind First quarter 2022 results: EPS: CN¥1.01 (up from CN¥0.30 in 1Q 2021). Revenue: CN¥2.61b (up 76% from 1Q 2021). Net income: CN¥534.3m (up 142% from 1Q 2021). Profit margin: 20% (up from 15% in 1Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 3.1%. Earnings per share (EPS) missed analyst estimates by 7.4%. Over the next year, revenue is expected to shrink by 4.4% compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Apr 06
Upcoming dividend of CN¥0.50 per share Eligible shareholders must have bought the stock before 13 April 2022. Payment date: 13 April 2022. Payout ratio is a comfortable 24% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of Chinese dividend payers (2.0%). Higher than average of industry peers (1.4%). Ankündigung • Apr 01
Lier Chemical Co.,LTD. Approves Cash Dividend (Tax Included) for 2021 Lier Chemical Co.,LTD. announced that at its Annual General Meeting held on 29 March 2022, approved cash dividend/10 shares (tax included) of CNY 5.00000000 for 2021. Valuation Update With 7 Day Price Move • Mar 15
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥28.18, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 73% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥49.60 per share. Ankündigung • Mar 10
Lier Chemical Co.,Ltd. Proposes Dividend for the Year 2021 Lier Chemical Co.,LTD. proposed cash dividend of CNY 5.00000000 (tax included) per 10 shares for year 2021. Reported Earnings • Mar 06
Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2021 results: EPS: CN¥2.04 (up from CN¥1.17 in FY 2020). Revenue: CN¥6.49b (up 31% from FY 2020). Net income: CN¥1.07b (up 75% from FY 2020). Profit margin: 17% (up from 12% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.1%. Earnings per share (EPS) missed analyst estimates by 7.4%. Over the next year, revenue is forecast to grow 13%, compared to a 48% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 29% per year whereas the company’s share price has increased by 33% per year. Reported Earnings • Jan 23
Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2021 results: EPS: CN¥2.04 (up from CN¥1.17 in FY 2020). Revenue: CN¥6.49b (up 31% from FY 2020). Net income: CN¥1.07b (up 75% from FY 2020). Profit margin: 17% (up from 12% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.1%. Earnings per share (EPS) missed analyst estimates by 100%. Over the next year, revenue is forecast to grow 13%, compared to a 40% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 29% per year whereas the company’s share price has increased by 28% per year. Reported Earnings • Oct 26
Third quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.31 in 3Q 2020) The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: CN¥1.12b (up 11% from 3Q 2020). Net income: CN¥106.7m (down 34% from 3Q 2020). Profit margin: 9.5% (down from 16% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 17% per year whereas the company’s share price has increased by 13% per year. Price Target Changed • Oct 26
Price target decreased to CN¥31.45 Down from CN¥34.20, the current price target is an average from 7 analysts. New target price is 29% above last closing price of CN¥24.31. Stock is up 19% over the past year. The company is forecast to post earnings per share of CN¥2.05 for next year compared to CN¥1.17 last year. Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment deteriorated over the past week After last week's 18% share price decline to CN¥28.25, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 51% over the past three years. Major Estimate Revision • Aug 13
Consensus revenue estimates increase to CN¥6.24b The consensus outlook for revenues in 2021 has improved. 2021 revenue forecast increased from CN¥5.63b to CN¥6.24b. EPS estimate increased from CN¥1.54 to CN¥2.21 per share. Net income forecast to grow 30% next year vs 41% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥32.85. Share price rose 6.9% to CN¥33.80 over the past week. Reported Earnings • Aug 09
Second quarter 2021 earnings released: EPS CN¥0.54 (vs CN¥0.33 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥1.68b (up 23% from 2Q 2020). Net income: CN¥284.2m (up 65% from 2Q 2020). Profit margin: 17% (up from 13% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Jul 26
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥30.04, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 56% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥29.84 per share. Valuation Update With 7 Day Price Move • Jun 29
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥26.38, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 42% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥29.34 per share. Reported Earnings • Apr 28
First quarter 2021 earnings released: EPS CN¥0.42 (vs CN¥0.16 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥1.48b (up 51% from 1Q 2020). Net income: CN¥220.8m (up 165% from 1Q 2020). Profit margin: 15% (up from 8.5% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 3% per year whereas the company’s share price has increased by 5% per year. Ankündigung • Mar 10
Lier Chemical Co.,LTD., Annual General Meeting, Mar 30, 2021 Lier Chemical Co.,LTD., Annual General Meeting, Mar 30, 2021, at 14:40 China Standard Time. Agenda: To consider 2020 work report of the board of directors; to consider 2020 work report of the supervisory committee; to consider 2020 annual accounts; to consider 2020 profit distribution plan; to consider 2020 annual report and its summary; to consider the application for loans and comprehensive credit line; to consider the provision of guarantee for a subsidiary; to consider the appointment of 2021 audit firm; to consider the change of the purpose of some raised funds to permanently supplement the working capital; to consider the amendments to the company's articles of association; to consider the amendments to the remuneration management measures for directors, supervisors and senior management; and to consider the amendments to the external guarantee decision-making system. Reported Earnings • Mar 07
Full year 2020 earnings released: EPS CN¥1.17 (vs CN¥0.59 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥4.97b (up 19% from FY 2019). Net income: CN¥612.2m (up 97% from FY 2019). Profit margin: 12% (up from 7.5% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings. Analyst Estimate Surprise Post Earnings • Mar 07
Revenue and earnings beat expectations Revenue exceeded analyst estimates by 0.3%. Earnings per share (EPS) also surpassed analyst estimates by 2.6%. Over the next year, revenue is forecast to grow 14%, compared to a 51% growth forecast for the Chemicals industry in China. Valuation Update With 7 Day Price Move • Feb 26
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥25.56, the stock is trading at a trailing P/E ratio of 21.8x, down from the previous P/E ratio of 25.8x. This compares to an average P/E of 37x in the Chemicals industry in China. Total returns to shareholders over the past three years are 23%. Is New 90 Day High Low • Feb 20
New 90-day high: CN¥30.25 The company is up 33% from its price of CN¥22.71 on 20 November 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 20% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥5.24 per share. Valuation Update With 7 Day Price Move • Feb 01
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥27.59, the stock is trading at a trailing P/E ratio of 23.5x, up from the previous P/E ratio of 20.2x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 36%. Is New 90 Day High Low • Jan 29
New 90-day high: CN¥25.24 The company is up 27% from its price of CN¥19.90 on 30 October 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 22% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥5.21 per share. Reported Earnings • Jan 23
Full year 2020 earnings released: EPS CN¥1.17 The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥4.97b (up 19% from FY 2019). Net income: CN¥615.2m (up 98% from FY 2019). Profit margin: 12% (up from 7.5% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings. Analyst Estimate Surprise Post Earnings • Jan 23
Revenue and earnings beat expectations Revenue exceeded analyst estimates by 0.3%. Earnings per share (EPS) also surpassed analyst estimates by 6.8%. Over the next year, revenue is forecast to grow 14%, compared to a 50% growth forecast for the Chemicals industry in China. Ankündigung • Jan 22
Lier Chemical Co.,LTD. to Report Fiscal Year 2020 Results on Mar 06, 2021 Lier Chemical Co.,LTD. announced that they will report fiscal year 2020 results on Mar 06, 2021 Valuation Update With 7 Day Price Move • Nov 16
Market bids up stock over the past week After last week's 18% share price gain to CN¥23.71, the stock is trading at a trailing P/E ratio of 25.2x, up from the previous P/E ratio of 21.3x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past three years are 73%. Reported Earnings • Oct 25
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥493.5m, up 26% from the prior year. Total revenue was CN¥4.50b over the last 12 months, up 5.2% from the prior year. Ankündigung • Oct 17
Lier Chemical Co.,LTD. to Report Q3, 2020 Results on Oct 24, 2020 Lier Chemical Co.,LTD. announced that they will report Q3, 2020 results on Oct 24, 2020 Is New 90 Day High Low • Oct 05
New 90-day low: CN¥19.38 The company is down 2.0% from its price of CN¥19.85 on 07 July 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.15 per share. Ankündigung • Jul 18
Lier Chemical Co.,LTD. to Report First Half, 2020 Results on Aug 06, 2020 Lier Chemical Co.,LTD. announced that they will report first half, 2020 results on Aug 06, 2020